• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Critical Insights From Surgery Partners Analyst Ratings: What You Need To Know

    6/28/24 8:00:16 AM ET
    $SGRY
    Hospital/Nursing Management
    Health Care
    Get the next $SGRY alert in real time by email

    In the latest quarter, 4 analysts provided ratings for Surgery Partners (NASDAQ:SGRY), showcasing a mix of bullish and bearish perspectives.

    The following table summarizes their recent ratings, shedding light on the changing sentiments within the past 30 days and comparing them to the preceding months.

    Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish
    Total Ratings 2 2 0 0 0
    Last 30D 0 1 0 0 0
    1M Ago 0 0 0 0 0
    2M Ago 2 0 0 0 0
    3M Ago 0 1 0 0 0

    In the assessment of 12-month price targets, analysts unveil insights for Surgery Partners, presenting an average target of $40.5, a high estimate of $50.00, and a low estimate of $31.00. Observing a downward trend, the current average is 11.96% lower than the prior average price target of $46.00.

    price target chart

    Diving into Analyst Ratings: An In-Depth Exploration

    The standing of Surgery Partners among financial experts is revealed through an in-depth exploration of recent analyst actions. The summary below outlines key analysts, their recent evaluations, and adjustments to ratings and price targets.

    Analyst Analyst Firm Action Taken Rating Current Price Target Prior Price Target
    Tao Qiu Macquarie Announces Outperform $31.00 -
    Jason Cassorla Citigroup Lowers Buy $38.00 $42.00
    Bill Sutherland Benchmark Maintains Buy $50.00 $50.00
    Sarah James Cantor Fitzgerald Maintains Overweight $43.00 -

    Key Insights:

    • Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Surgery Partners. This information provides a snapshot of how analysts perceive the current state of the company.
    • Rating: Gaining insights, analysts provide qualitative assessments, ranging from 'Outperform' to 'Underperform'. These ratings reflect expectations for the relative performance of Surgery Partners compared to the broader market.
    • Price Targets: Analysts explore the dynamics of price targets, providing estimates for the future value of Surgery Partners's stock. This examination reveals shifts in analysts' expectations over time.

    Considering these analyst evaluations in conjunction with other financial indicators can offer a comprehensive understanding of Surgery Partners's market position. Stay informed and make well-informed decisions with our Ratings Table.

    Stay up to date on Surgery Partners analyst ratings.

    Discovering Surgery Partners: A Closer Look

    Surgery Partners Inc is a healthcare services company with an integrated outpatient delivery model focused on providing quality, cost-effective solutions for surgical and related ancillary care in support of both patients and physicians. It operates in two segments: Surgical Facility Services and Ancillary Services out of which the Surgical Facility Services segment accounts for the majority of revenue.

    Surgery Partners's Economic Impact: An Analysis

    Market Capitalization Perspectives: The company's market capitalization falls below industry averages, signaling a relatively smaller size compared to peers. This positioning may be influenced by factors such as perceived growth potential or operational scale.

    Positive Revenue Trend: Examining Surgery Partners's financials over 3 months reveals a positive narrative. The company achieved a noteworthy revenue growth rate of 7.69% as of 31 March, 2024, showcasing a substantial increase in top-line earnings. In comparison to its industry peers, the company trails behind with a growth rate lower than the average among peers in the Health Care sector.

    Net Margin: Surgery Partners's net margin is below industry averages, indicating potential challenges in maintaining strong profitability. With a net margin of -1.73%, the company may face hurdles in effective cost management.

    Return on Equity (ROE): Surgery Partners's ROE is below industry standards, pointing towards difficulties in efficiently utilizing equity capital. With an ROE of -0.63%, the company may encounter challenges in delivering satisfactory returns for shareholders.

    Return on Assets (ROA): Surgery Partners's ROA falls below industry averages, indicating challenges in efficiently utilizing assets. With an ROA of -0.18%, the company may face hurdles in generating optimal returns from its assets.

    Debt Management: Surgery Partners's debt-to-equity ratio is below industry norms, indicating a sound financial structure with a ratio of 1.61.

    How Are Analyst Ratings Determined?

    Analysts are specialists within banking and financial systems that typically report for specific stocks or within defined sectors. These people research company financial statements, sit in conference calls and meetings, and speak with relevant insiders to determine what are known as analyst ratings for stocks. Typically, analysts will rate each stock once a quarter.

    In addition to their assessments, some analysts extend their insights by offering predictions for key metrics such as earnings, revenue, and growth estimates. This supplementary information provides further guidance for traders. It is crucial to recognize that, despite their specialization, analysts are human and can only provide forecasts based on their beliefs.

    This article was generated by Benzinga's automated content engine and reviewed by an editor.

    Get the next $SGRY alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $SGRY

    DatePrice TargetRatingAnalyst
    9/18/2025$27.00Neutral
    Analyst
    7/28/2025$28.00Buy
    BofA Securities
    12/16/2024$30.00Buy
    BofA Securities
    10/14/2024$38.00Buy
    UBS
    10/11/2024Sector Weight
    KeyBanc Capital Markets
    6/28/2024$31.00Outperform
    Macquarie
    3/6/2024$35.00Equal Weight
    Barclays
    11/14/2023$39.00 → $35.00Market Perform → Outperform
    TD Cowen
    More analyst ratings

    $SGRY
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    COO & National Group President Oppenheimer Justin Robert was granted 77,736 shares (SEC Form 4)

    4 - Surgery Partners, Inc. (0001638833) (Issuer)

    1/15/26 5:09:02 PM ET
    $SGRY
    Hospital/Nursing Management
    Health Care

    New insider Oppenheimer Justin Robert claimed no ownership of stock in the company (SEC Form 3)

    3 - Surgery Partners, Inc. (0001638833) (Issuer)

    1/9/26 4:03:01 PM ET
    $SGRY
    Hospital/Nursing Management
    Health Care

    National Group President Bane Harrison R. sold $209,941 worth of shares (9,339 units at $22.48), decreasing direct ownership by 7% to 117,181 units (SEC Form 4)

    4 - Surgery Partners, Inc. (0001638833) (Issuer)

    9/8/25 4:29:17 PM ET
    $SGRY
    Hospital/Nursing Management
    Health Care

    $SGRY
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Analyst resumed coverage on Surgery Partners with a new price target

    Analyst resumed coverage of Surgery Partners with a rating of Neutral and set a new price target of $27.00

    9/18/25 8:45:00 AM ET
    $SGRY
    Hospital/Nursing Management
    Health Care

    BofA Securities resumed coverage on Surgery Partners with a new price target

    BofA Securities resumed coverage of Surgery Partners with a rating of Buy and set a new price target of $28.00

    7/28/25 9:00:02 AM ET
    $SGRY
    Hospital/Nursing Management
    Health Care

    BofA Securities initiated coverage on Surgery Partners with a new price target

    BofA Securities initiated coverage of Surgery Partners with a rating of Buy and set a new price target of $30.00

    12/16/24 6:50:04 AM ET
    $SGRY
    Hospital/Nursing Management
    Health Care

    $SGRY
    SEC Filings

    View All

    Amendment: SEC Form SCHEDULE 13G/A filed by Surgery Partners Inc.

    SCHEDULE 13G/A - Surgery Partners, Inc. (0001638833) (Subject)

    2/17/26 5:17:09 PM ET
    $SGRY
    Hospital/Nursing Management
    Health Care

    Amendment: SEC Form SCHEDULE 13G/A filed by Surgery Partners Inc.

    SCHEDULE 13G/A - Surgery Partners, Inc. (0001638833) (Subject)

    2/5/26 1:40:12 PM ET
    $SGRY
    Hospital/Nursing Management
    Health Care

    Surgery Partners Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation, Financial Statements and Exhibits

    8-K - Surgery Partners, Inc. (0001638833) (Filer)

    12/16/25 4:01:52 PM ET
    $SGRY
    Hospital/Nursing Management
    Health Care

    $SGRY
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Surgery Partners, Inc. Announces Pricing of Add-On Notes Offering

    BRENTWOOD, Tenn., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company") today announced that its wholly-owned subsidiary, Surgery Center Holdings, Inc. (the "Issuer"), priced $425.0 million aggregate principal amount of its 7.250% senior unsecured notes due 2032 (the "Notes") in a previously announced private offering exempt from the registration requirements of the Securities Act of 1933, as amended (the "Securities Act"). The offering is expected to close on December 16, 2025, subject to certain customary closing conditions. The Notes will be guaranteed (the "Guarantees") on a senior unsecured basis by each domestic wholly-owned subs

    12/11/25 6:25:32 PM ET
    $SGRY
    Hospital/Nursing Management
    Health Care

    Surgery Partners, Inc. Announces Add-On Senior Notes Offering

    BRENTWOOD, Tenn., Dec. 11, 2025 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced today that Surgery Center Holdings, Inc., a wholly owned subsidiary of the Company (the "Issuer"), intends to offer, subject to market and other considerations, an additional $425.0 million aggregate principal amount of its 7.250% senior unsecured notes due 2032 (the "Notes"). The Notes will be guaranteed (the "Guarantees") on a senior unsecured basis by each domestic wholly-owned subsidiary of the Issuer that guarantees its obligations under its senior secured credit facilities. The notes will b

    12/11/25 8:23:47 AM ET
    $SGRY
    Hospital/Nursing Management
    Health Care

    Surgery Partners and Baylor Scott & White Health Form Joint Venture to Expand Access to Quality Care

    BRENTWOOD, Tenn., and BRYAN/COLLEGE STATION, Texas, Dec. 08, 2025 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) announces a new partnership with Baylor Scott & White Health, the largest not-for-profit health system in Texas, to jointly own with physicians the 16-bed hospital in Bryan known as The Physicians Centre Hospital*. Patients will be able to continue care with their current provider at the location. The hospital will operate under the Baylor Scott & White name in the future, with Surgery Partners continuing to manage daily operations. The hospital has been recognized for surgical excellence and patient satisfaction. It offers a broad range of surgical options for bariat

    12/8/25 12:00:00 PM ET
    $SGRY
    Hospital/Nursing Management
    Health Care

    $SGRY
    Leadership Updates

    Live Leadership Updates

    View All

    Surgery Partners, Inc. Names Laura L. Forese, MD to Board of Directors

    BRENTWOOD, Tenn., Jan. 13, 2025 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company") today announced that Dr. Laura L. Forese has been appointed to serve as an independent director on its Board of Directors. Dr. Forese's appointment, which is effective January 10, 2025, will increase the size of Surgery Partners' Board to eleven members. Dr. Forese joins the Surgery Partners Board with extensive healthcare experience. Her career in healthcare administration spans over 40 years, most recently serving as an executive vice president and chief operating officer for New York-Presbyterian, one of the nation's most comprehensive, integrated academic heal

    1/13/25 5:00:24 PM ET
    $SGRY
    Hospital/Nursing Management
    Health Care

    Teladoc Health Appoints Leading Healthcare and Hospitals Executive Eric Evans to Board of Directors

    PURCHASE, NY, Sept. 20, 2023 (GLOBE NEWSWIRE) -- Teladoc Health, Inc. (NYSE:TDOC), the global leader in whole-person virtual care, today appointed Eric Evans to the company's board of directors. Mr. Evans, currently chief executive officer and director of Brentwood, TN-based Surgery Partners, Inc. (NASDAQ:SGRY), is a recognized healthcare and hospital executive with significant experience leading complex organizations operating at the intersection of care and technology. Mr. Evans joins the board following the retirement of Senator William Frist, M.D. earlier this year, and will serve on the board's compensation committee. David B. Snow, Jr., non-executive Chairman of the company's board,

    9/20/23 8:05:00 AM ET
    $SGRY
    $TDOC
    Hospital/Nursing Management
    Health Care
    Medical/Nursing Services

    Akumin Provides Business Update and Announces CFO Transition

    PLANTATION, Fla., Aug. 12, 2022 /PRNewswire/ - Akumin Inc. (NASDAQ:AKU) (TSX:AKU) ("Akumin" or the "Company") provided a business update and announced the termination of employment of its Chief Financial Officer, William Larkin and the appointment of David Kretschmer as Interim Chief Financial Officer, effective today. The Company has implemented a transformation program with initiatives focused on its operations, growth, and capital. These initiatives are intended to support the Company's objectives with respect to patient access and experience, customer and partner engagement, financial sustainability, and employee well-being. The Company is receiving support from a globally recognized tr

    8/12/22 5:56:00 PM ET
    $AKU
    $ELV
    $SGRY
    Medical Specialities
    Health Care
    Hospital/Nursing Management

    $SGRY
    Financials

    Live finance-specific insights

    View All

    Surgery Partners, Inc. Announces Third Quarter 2025 Results

    BRENTWOOD, Tenn., Nov. 10, 2025 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, today announced results for the third quarter ended September 30, 2025. Third Quarter 2025 Financial Highlights (All comparisons are year-over-year unless otherwise noted) Revenue increased 6.6% for the third quarter Same-facility revenues increased 6.3% for the third quarter Surgical cases increased 2.1% for the third quarter Same-facility cases increased 3.4% for the third quarter Net loss attributable to Surgery Partners, Inc. was $22.7 million for the third quarter Adjusted EBITDA increased 6.1% to

    11/10/25 7:30:00 AM ET
    $SGRY
    Hospital/Nursing Management
    Health Care

    Surgery Partners, Inc. Announces Third Quarter 2025 Earnings Release Date and Conference Call Details

    BRENTWOOD, Tenn., Oct. 24, 2025 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, announced the Company will release its third quarter 2025 results before the market opens on Monday, November 10, 2025, to be followed by a conference call at 8:30 a.m. (Eastern Time). You can join the call as follows: Dial in number for live access: 1-877-451-6152 (domestic), 1-201-389-0879 (international)Replay (available 3 hours after the call and available until November 24, 2025): 1-844-512-2921 (domestic), 1-412-317-6671 (international)Passcode for the live call and the replay: 13756022 Interested

    10/24/25 7:07:03 PM ET
    $SGRY
    Hospital/Nursing Management
    Health Care

    Surgery Partners, Inc. Announces Second Quarter 2025 Results

    BRENTWOOD, Tenn., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Surgery Partners, Inc. (NASDAQ:SGRY) ("Surgery Partners" or the "Company"), a leading short-stay surgical facility owner and operator, today announced results for the second quarter ended June 30, 2025. Second Quarter 2025 Financial Highlights (All comparisons are year-over-year unless otherwise noted) Revenue increased 8.4% for the second quarter Same-facility revenues increased 5.1% for the second quarterSame-facility cases increased 3.4% for the second quarter Net loss attributable to Surgery Partners, Inc. was $2.5 million for the second quarter Adjusted EBITDA increased 9.0% to $129.0 million for the second quarter 2025 Guidance

    8/5/25 7:30:00 AM ET
    $SGRY
    Hospital/Nursing Management
    Health Care

    $SGRY
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13G/A filed by Surgery Partners Inc.

    SC 13G/A - Surgery Partners, Inc. (0001638833) (Subject)

    11/8/24 10:46:38 AM ET
    $SGRY
    Hospital/Nursing Management
    Health Care

    SEC Form SC 13G filed by Surgery Partners Inc.

    SC 13G - Surgery Partners, Inc. (0001638833) (Subject)

    10/24/24 2:02:10 PM ET
    $SGRY
    Hospital/Nursing Management
    Health Care

    SEC Form SC 13G/A filed by Surgery Partners Inc. (Amendment)

    SC 13G/A - Surgery Partners, Inc. (0001638833) (Subject)

    2/13/24 5:15:54 PM ET
    $SGRY
    Hospital/Nursing Management
    Health Care